CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Escitalopram +2 moredrug
Likely dose
Escitalopram 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00601965
NCT00601965N/ACompleted
CompareCT.gov

CBT Augmentation of SSRI Treatment for Geriatric GAD

Veterans Medical Research Foundation·interventional·Posted Jan 28, 2008·Updated Aug 25, 2016

In Brief

A clinical study evaluating Escitalopram, Placebo, and 1 other intervention for Generalized Anxiety Disorder. Completed, enrolled 73 participants across 3 sites.

Detailed Summary

This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGeneralized Anxiety Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 28, 2008
Enrollment StartOct 1, 2007
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 18.4 years ago

Interventions

Escitalopramdrug

20 mg daily oral escitalopram

Placebodrug

Placebo pill of daily oral escitalopram

Cognitive behavioral therapy (CBT)behavioral

16 weekly 1-hour sessions